|
1
|
Hassa PO, Haenni SS, Elser M and Hottiger
MO: Nuclear ADP-ribosylation reactions in mammalian cells: where
are we today and where are we going? Microbiol Mol Biol Rev.
70:789–829. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Otto H, Reche PA, Bazan F, Dittmar K, Haag
F and Koch-Nolte F: In silico characterization of the family
of PARP-like poly(ADP-ribosyl)transferases (pARTs). BMC Genomics.
6:1392005. View Article : Google Scholar
|
|
3
|
Ueda K and Hayaishi O: ADP-ribosylation.
Annu Rev Biochem. 54:73–100. 1985. View Article : Google Scholar
|
|
4
|
Corda D and Di Girolamo M:
Mono-ADP-ribosylation: a tool for modulating immune response and
cell signaling. Sci STKE. 2002:pe532002.PubMed/NCBI
|
|
5
|
Corda D and Di Girolamo M: Functional
aspects of protein mono-ADP-ribosylation. EMBO J. 22:1953–1958.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Z, Gruszczynska-Biegala J and
Zolkiewska A: ADP-ribosylation of integrin α7 modulates the binding
of integrin α7β1 to laminin. Biochem J. 385:309–317. 2005.
|
|
7
|
Okazaki IJ, Zolkiewska A, Nightingale MS
and Moss J: Immunological and structural conservation of mammalian
skeletal muscle glycosylphosphatidylinositol-linked
ADP-ribosyltransferases. Biochemistry. 33:12828–12836. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zolkiewska A, Nightingale MS and Moss J:
Molecular characterization of NAD:arginine ADP-ribosyltransferase
from rabbit skeletal muscle. Proc Natl Acad Sci USA.
89:11352–11356. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paone G, Stevens LA, Levine RL, et al:
ADP-ribosyltransferase-specific modification of human neutrophil
peptide-1. J Biol Chem. 281:17054–17060. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yau L, Litchie B, Thomas S, Storie B,
Yurkova N and Zahradka P: Endogenous mono-ADP-ribosylation mediates
smooth muscle cell proliferation and migration via protein kinase
N-dependent induction of c-fos expression. Eur J Biochem.
270:101–110. 2003. View Article : Google Scholar
|
|
11
|
Gilcrease MZ: Integrin signaling in
epithelial cells. Cancer Lett. 247:1–25. 2007. View Article : Google Scholar
|
|
12
|
Takeba Y, Matsumoto N, Watanabe M, et al:
The Rho kinase inhibitor fasudil is involved in p53-mediated
apoptosis in human hepatocellular carcinoma cells. Cancer Chemother
Pharmacol. 69:1545–1555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hippenstiel S, Schmeck B, N’Guessan PD, et
al: Rho protein inactivation induced apoptosis of cultured human
endothelial cells. Am J Physiol Lung Cell Mol Physiol.
283:L830–L838. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kirkland JB: Poly ADP-ribose polymerase-1
and health. Exp Biol Med. 235:561–568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu JX, Wang YL, Tang Y and Xiong W: Effect
of ART1 gene silencing by RNA interference on the proliferation of
mouse colon carcinoma cells and its possible mechanism. TUMOR.
32:949–954. 2012.
|
|
16
|
Li Q, Li M, Wang YL, et al: RNA
interference of PARG could inhibit the metastatic potency of colon
carcinoma cells via PI3-kinase/Akt pathway. Cell Physiol Biochem.
29:361–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fauzee NJ, Li Q, Wang YL and Pan J:
Silencing poly (ADP-ribose) glycohydrolase (PARG) expression
inhibits growth of human colon cancer cells in vitro via
PI3K/Akt/NFκ-B pathway. Pathol Oncol Res. 18:191–199.
2012.PubMed/NCBI
|
|
18
|
Fauzee NJ, Pan J and Wang YL: PARP and
PARG inhibitors - new therapeutic targets in cancer treatment.
Pathol Oncol Res. 16:469–478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye K: PARP inhibitor tilts cell death from
necrosis to apoptosis in cancer cells. Cancer Biol Ther. 7:942–944.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang Y, Wang YL, Yang L, et al: Inhibition
of arginine ADP-ribosyltransferase 1 reduces the expression of
poly(ADP-ribose) polymerase-1 in colon carcinoma. Int J Mol Med.
32:130–136. 2013.PubMed/NCBI
|
|
21
|
Furuya K, Ozaki T, Hanamoto T, et al:
Stabilization of p73 by nuclear IκB kinase-α mediates
cisplatin-induced apoptosis. J Biol Chem. 282:18365–18378.
2007.
|
|
22
|
Ohnishi K, Ota I, Takahashi A, Yane K,
Matsumoto H and Ohnishi T: Transfection of mutant p53 gene
depresses X-ray- or CDDP-induced apoptosis in a human squamous cell
carcinoma of the head and neck. Apoptosis. 7:367–372. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Houdt WJ, Hoogwater FJ, de Bruijn MT,
et al: Oncogenic KRAS desensitizes colorectal tumor cells to
epidermal growth factor receptor inhibition and activation.
Neoplasia. 12:443–452. 2010.PubMed/NCBI
|
|
24
|
Benitah SA, Valerón PF and Lacal JC: ROCK
and nuclear factor-κB-dependent activation of cyclooxygenase-2 by
Rho GTPases: effects on tumor growth and therapeutic consequences.
Mol Biol Cell. 14:3041–3054. 2003.
|
|
25
|
Zhang Z, Lai GH and Sirica AE:
Celecoxib-induced apoptosis in rat cholangiocarcinoma cells
mediated by Akt inactivation and Bax translocation. Hepatology.
39:1028–1037. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lax AJ and Thomas W: How bacteria could
cause cancer: one step at a time. Trends Microbiol. 10:293–299.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nicholson DW and Thornberry NA: Caspases:
killer proteases. Trends Biochem Sci. 22:299–306. 1997. View Article : Google Scholar
|
|
28
|
Yin MJ, Yamamoto Y and Gaynor RB: The
anti-inflammatory agents aspirin and salicylate inhibit the
activity of IκB kinase-β. Nature. 396:77–80. 1998.
|
|
29
|
Cai L, Threadgill MD, Wang Y and Li M:
Effect of poly (ADP-ribose) polymerase-1 inhibition on the
proliferation of murine colon carcinoma CT26 cells. Pathol Oncol
Res. 15:323–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chiti F, Stefani M, Taddei N, Ramponi G
and Dobson CM: Rationalization of the effects of mutations on
peptide and protein aggregation rates. Nature. 424:805–808. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hassa PO and Hottiger MO: The functional
role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB
in inflammatory disorders. Cell Mol Life Sci. 59:1534–1553.
2002.PubMed/NCBI
|
|
32
|
Ratnam K and Low JA: Current development
of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
Clin Cancer Res. 13:1383–1388. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jagtap P and Szabó C: Poly(ADP-ribose)
polymerase and the therapeutic effects of its inhibitors. Nat Rev
Drug Discov. 4:421–440. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schreiber V, Dantzer F, Ame JC and De
Murcia G: Poly(ADP-ribose): novel functions for an old molecule.
Nat Rev Mol Cell Biol. 7:517–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J and Yuan J: Caspases in apoptosis and
beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim JW, Kim K, Kang K and Joe CO:
Inhibition of homodimerization of poly(ADP-ribose) polymerase by
its C-terminal cleavage products produced during apoptosis. J Biol
Chem. 275:8121–8125. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JW, Won J, Sohn S and Joe CO:
DNA-binding activity of the N-terminal cleavage product of
poly(ADP-ribose) polymerase is required for UV mediated apoptosis.
J Cell Sci. 113:955–961. 2000.PubMed/NCBI
|
|
38
|
D’Ambrosio SM, Gibson-D’Ambrosio RE, Brady
T, Oberyszyn AS and Robertson FM: Mechanisms of nitric
oxide-induced cytotoxicity in normal human hepatocytes. Environ Mol
Mutagen. 37:46–54. 2001.PubMed/NCBI
|
|
39
|
Chaitanya GV, Steven AJ and Babu PP:
PARP-1 cleavage fragments: signatures of cell-death proteases in
neurodegeneration. Cell Commun Signal. 8:312010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soldani C and Scovassi A: Poly(ADP-ribose)
polymerase-1 cleavage during apoptosis: an update. Apoptosis.
7:321–328. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Virág L and Szabó C: The therapeutic
potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev.
54:375–429. 2002.
|
